Healthtech Startups

EpiBone engineers bone tissue from stem cells for regenerative medicine and clinical reconstruction, serving patients requiring bone grafts or craniofacial repair. The company translates tissue engineering research into therapeutic products for orthopedic and surgical applications.

7 investors

Epsilogen develops antibody therapeutics based on the IgE, IgA, and IgG immunoglobulin isotypes for the treatment of cancer, matching each isotype to specific tumor types and combining isotypes into single antibody molecules. Its lead candidate, MOv18 IgE, targets folate receptor alpha and is in clinical development for ovarian cancer.

7 investors

Eyebot develops technology solutions for vision care, serving retailers, patients, and eye doctors to improve vision care delivery and access.

7 investors

F2G is a biotechnology company developing novel antifungal therapies to treat rare, life-threatening fungal infections in defined patient populations. Its work centers on new drug science aimed at expanding treatment options against fungal pathogens.

7 investors

Fellow operates a CLIA-certified diagnostics lab offering mail-in semen analysis for vasectomy and fertility testing, delivering clinically valid results without an in-person lab visit. It serves patients and clinics such as urologists and reproductive specialists, and conducts research into male reproductive health.

7 investors

Fi develops smart collars and wearable technology for dogs that track location, safety, and health metrics to help dog owners monitor their pets' wellbeing. The company serves dog owners with real-time tracking, health insights, and wellness monitoring features.

7 investors

Fitbit designs and develops wearable fitness tracking devices and associated software that monitor health metrics and physical activity.

7 investors

Flatiron Health combines AI-powered technology and clinical expertise with real-world oncology data to help healthcare providers and life science organizations improve cancer care and research. The company operates a global oncology platform serving community oncologists and research institutions across the US, UK, Germany, and Japan.

7 investors

Flywheel provides a platform for organizing, managing, and sharing medical imaging data. The company serves pharmaceutical companies, medical device manufacturers, AI developers, and academic medical centers to accelerate clinical trials, advance AI development, and streamline research workflows.

7 investors

Folia Health is a digital health platform that enables patients and caregivers to track symptoms, treatments, and health outcomes through personalized surveys, generating home-reported outcomes data used by life sciences companies and researchers to understand real-world treatment impacts. The company operates a data-sharing model where users receive Data Dividends in exchange for contributing their health information to clinical research programs.

7 investors

Formation Bio develops drugs through partnerships with health systems, academic medical centers, and research sites, focusing on clinical trials in dermatology, rheumatology, and cardiometabolic diseases. The company provides trial management infrastructure, monitoring, technology, and enrollment support to accelerate drug development.

7 investors

Genomics company building a multi-ancestry biobank and AI-driven analytics for clinical genetic testing and drug discovery.

7 investors

Gallant develops regenerative medicine therapies for veterinary care, bringing treatments from laboratory research into clinical practice for pets.

7 investors

Fabric unifies virtual and in-person care through technology for intake, triage, routing, and treatment, serving healthcare providers and patients. The company automates clinical and administrative workflows to improve care delivery efficiency and patient access.

7 investors

Handspring provides virtual, evidence-based mental health therapy for children, teens, and young adults, primarily using cognitive behavioral therapy along with medication management and parent training. It serves families across the US, offering insurance-covered care with free initial consultations.

7 investors

Teladoc Health operates a virtual care platform connecting patients with care providers for medical care, mental health, and chronic disease management services. The company serves health plans, employers, and hospital systems across the United States.

7 investors

Healthie provides a software platform for healthcare practitioners including dietitians and life coaches to manage their practices and deliver virtual, recurring care to patients outside traditional hospital settings.

7 investors

HealthJoy provides a benefits navigation platform that unifies an employer's benefits package into a single app, using AI-powered and human-backed support to guide employees to high-value care and boost benefits utilization. It serves benefits consultants, employers/HR teams, and their members, aiming to lower healthcare costs and improve engagement.

7 investors

Heartseed develops cardiac regenerative medicine, creating heart muscle cells from iPS cells for transplantation to treat heart failure, with its lead pipeline HS-001 nearing clinical trials. The company targets patients with heart failure caused by conditions such as myocardial infarction, with reference markets in Japan and the US.

7 investors

Heidi builds an AI Care Partner platform that augments clinical workflows through an AI scribe and a medical research tool called Evidence, serving clinicians across hospitals and healthcare systems globally. The platform supports millions of weekly consultations across 110 languages and 190 countries.

7 investors

HotSpot Therapeutics is a drug discovery company developing small-molecule allosteric medicines by targeting "natural hotspots" — regulatory on/off switches on proteins. Its Smart Allostery platform combines structure-function analysis, pharmacology, chemistry, and AI to discover treatments for autoimmune diseases.

7 investors

Humane Genomics develops oncolytic viral therapies designed to selectively target and kill cancer cells using engineered RNA viruses, particularly Vesicular Stomatitis Virus. The company leverages a computational platform for viral genome design and engineering to create cancer treatments with improved safety, efficacy, and manufacturing efficiency.

7 investors

Immusoft develops a cell therapy platform called Immune System Programming (ISP) that engineers a patient's B cells into plasma cells that produce therapeutic proteins after being infused back into the patient. The company focuses on personalized protein therapeutics for patients.

7 investors

Infiuss Health operates a decentralized clinical research platform that connects pharmaceutical sponsors with patient participants, physicians, and hospitals to conduct remote or hybrid clinical trials. The platform aims to accelerate drug development by diversifying participant cohorts and streamlining the recruitment and management of clinical studies.

7 investors